The WinFood Intervention Study: the effect of improved complementary foods on nutrition and health among infants in Western Kenya

The WinFood Intervention Study: randomised controlled trial of the effect of improved complementary foods on infant growth, body composition and gross motor development in Western Kenya

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN30012997

Enrollment

450

Registered

2012-05-11

Start date

2012-01-15

Completion date

Unknown

Last updated

2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants at risk of undernutrition Nutritional, Metabolic, Endocrine

Interventions

Three different pre-cooked complementary food supplements given as a porridge daily from 6-15 months of age (6-8 months: 50 g, 9-12 months: 75 g, 13-15 months: 125 g) 1. WinFood CF: am

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children who are 6 months old and have a weight-for-height z-score > -3

Exclusion criteria

Exclusion criteria: 1. Weight-for-height z-score < -3 2. Bilateral pitting oedema 3. Haemoglobin (Hb) < 80 g/L 4. Clinical signs of vitamin A deficiency (xerosis or Bitot spots). These children will be referred for treatment

Design outcomes

Primary

Measure	Time frame
Changes in linear growth (stunting), fat-free body mass (deuterium dilution), iron status (serum ferritin and transferrin receptors) from baseline (age 6 months) until the end of the 9 month intervention	—

Secondary

Measure	Time frame
Changes in: 1. Physical activity (using an accelerometer, actigraph) 2. Motor milestones (questionnaire, clinic visits) 3. Morbidity 4. Haemoglobin concentration (using Haemocue) 5. Serum concentrations of acute phase proteins [C-reactive protein (CRP) and a-acid glycoprotein(AGP)], insulin-like growth factor (IGF)-1 and zinc 6. Whole blood fatty acid composition Measured from baseline (age 6 months) until the end of the 9 month intervention	—

Measure

Time frame

Changes in: 1. Physical activity (using an accelerometer, actigraph) 2. Motor milestones (questionnaire, clinic visits) 3. Morbidity 4. Haemoglobin concentration (using Haemocue) 5. Serum concentrations of acute phase proteins [C-reactive protein (CRP) and a-acid glycoprotein(AGP)], insulin-like growth factor (IGF)-1 and zinc 6. Whole blood fatty acid composition Measured from baseline (age 6 months) until the end of the 9 month intervention

—

Countries

Denmark, Kenya

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 12, 2026